Beneficial outcomes of omega-6 and omega-3 polyunsaturated fatty acids on human health: An update for 2021

I Djuricic, PC Calder - Nutrients, 2021 - mdpi.com
Oxidative stress and inflammation have been recognized as important contributors to the risk
of chronic non-communicable diseases. Polyunsaturated fatty acids (PUFAs) may regulate …

Update on omega-3 polyunsaturated fatty acids on cardiovascular health

D Rodriguez, CJ Lavie, A Elagizi, RV Milani - Nutrients, 2022 - mdpi.com
Twenty percent of deaths in the United States are secondary to cardiovascular diseases
(CVD). In patients with hyperlipidemia and hypertriglyceridemia, studies have shown high …

Health implications of high dietary omega‐6 polyunsaturated fatty acids

E Patterson, R Wall, GF Fitzgerald… - Journal of nutrition …, 2012 - Wiley Online Library
Omega‐6 (n‐6) polyunsaturated fatty acids (PUFA)(eg, arachidonic acid (AA)) and omega‐3
(n‐3) PUFA (eg, eicosapentaenoic acid (EPA)) are precursors to potent lipid mediator …

Omega-3 polyunsaturated fatty acid biomarkers and risk of type 2 diabetes, cardiovascular disease, cancer, and mortality

H Jiang, L Wang, D Wang, N Yan, C Li, M Wu, F Wang… - Clinical Nutrition, 2022 - Elsevier
Background & aims Considerable attention has focused on the role of omega-3
polyunsaturated fatty acids (PUFA) in the prevention of cardiometabolic diseases, which has …

[HTML][HTML] The potential cardiometabolic effects of long-chain omega-3 polyunsaturated fatty acids: recent updates and controversies

JH Bae, H Lim, S Lim - Advances in Nutrition, 2023 - Elsevier
Various health-related effects of long-chain (LC) omega-3 polyunsaturated fatty acids
(PUFAs), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), have been …

Effects of omega-3 polyunsaturated fatty acids and their metabolites on haemostasis—current perspectives in cardiovascular disease

J Golanski, P Szymanska, M Rozalski - International journal of molecular …, 2021 - mdpi.com
The beneficial effects of long-chain polyunsaturated omega-3 fatty acids (omega-3 PUFAs)
in cardioprotection are widely known and generally accepted. In this literature review, we …

[HTML][HTML] Stimulating the resolution of inflammation through omega-3 polyunsaturated fatty acids in COVID-19: rationale for the COVID-omega-F trial

H Arnardottir, SC Pawelzik… - Frontiers in …, 2021 - frontiersin.org
Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes
coronavirus disease 2019 (COVID-19). SARS-CoV-2 triggers an immune response with …

May omega-3 fatty acid dietary supplementation help reduce severe complications in Covid-19 patients?

P Weill, C Plissonneau, P Legrand, V Rioux, R Thibault - Biochimie, 2020 - Elsevier
In around 10% of SARS-CoV-2 infected patients, coronavirus disease-2019 (Covid-19)
symptoms are complicated with a severe lung damage called Acute Respiratory Distress …

[HTML][HTML] N-3 polyunsaturated fatty acids: relationship to inflammation in healthy adults and adults exhibiting features of metabolic syndrome

LE Robinson, VC Mazurak - Lipids, 2013 - Springer
Individuals with metabolic syndrome (MetS) have a higher risk of type 2 diabetes and
cardiovascular disease, therefore, research has been directed at reducing various …

Marine omega-3 (N-3) fatty acids for cardiovascular health: an update for 2020

JK Innes, PC Calder - International journal of molecular sciences, 2020 - mdpi.com
The omega-3 (n-3) fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid
(DHA), are found in seafood (especially fatty fish), supplements and concentrated …